Indexed in Journament

Annals of oncology : official journal of the European Society for Medical Oncology

ISSN 0923-7534· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
41.2/100
Journament Score
#5,400
Journament Rank
14
Articles Indexed

About This Journal

Short Name Ann Oncol
Abbreviated Name ann oncol
ISSN 0923-7534
URL https://www.sciencedirect.com/journal/annals-of-oncology

Indexings

ncbi

Tools & Certificate of Indexing

Certificate of Indexing
Quality Badge Widget - Embed on Your Website

Display your journal's verified indexing scores on your website with our self-contained widget.

One-Line JavaScript Embed:
Advantages: Single-line script, seamless DOM integration, clickable badges linking to full journal profile.
Standard iFrame Embed Code:
Widget Preview:

Publications Per Year

Articles (14)

2020
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
Fabi A;Bhargava R;Fatigoni S;Guglielmo M;Horneber M;Roila F;Weis J;Jordan K;Ripamonti CI; ;;
Vol. 31 , No. 6 , pp. -
600 views Abstract
2007
The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry
Delpech Y;Cortez A;Coutant C;Callard P;Uzan S;Darai E;Barranger E;;
Vol. 18 , No. 11 , pp. -
435 views Abstract
2019
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange, M;Joly, F;Vardy, J;Ahles, T;Dubois, M;Tron, L;Winocur, G;De Ruiter, M B;Castel, H;
Vol. 30 , No. 12 , pp. 1925-1940
375 views DOI Abstract
2019
A three-year study of epidemiological trends of gastrointestinal cancers in a Haitian cancer program.
Bernard, J;Gilbert, D;Germain, R;Alexis, L;DeGennaro, V;
Vol. 30 Suppl 4 , pp. iv20
371 views DOI
2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Jhaveri, K L;Wang, X V;Makker, V;Luoh, S-W;Mitchell, E P;Zwiebel, J A;Sharon, E;Gray, R J;Li, S;McShane, L M;Rubinstein, L V;Patton, D;Williams, P M;Hamilton, S R;Conley, B A;Arteaga, C L;Harris, L N;O'Dwyer, P J;Chen, A P;Flaherty, K T;
Vol. 30 , No. 11 , pp. 1821-1830
369 views DOI Abstract
2020
A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore.
Ngoi, Natalie;Lim, Joline;Ow, Samuel;Jen, Wei Ying;Lee, Matilda;Teo, Winnie;Ho, Jingshan;Sundar, Raghav;Tung, Moon Ley;Lee, Yee Mei;Ngo, Ednajoy;Lim, Siew Woon;Ong, Jason;Lim, Frances;Bonney, Glenn;Vellayappan, Balamurugan;Ho, Francis;Tey, Jeremy;Chan, Noreen;de Mel, Sanjay;Poon, Michelle;Lee, Shir Ying;Koh, Liang Piu;Liu, Te Chih;Tan, Lip Kun;Wong, Alvin;Wong, Andrea;Lim, Siew Eng;Yeoh, Allen;Wong, John El;Tan, David;Goh, Boon Cher;Chng, Wee Joo;Soo, Ross;Chee, Cheng Ean;Chee, Yen Lin;Lee, Soo Chin;Jeyasekharan, Anand D;, ;
357 views DOI
2016
Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned.
Friedlander, M;Mercieca-Bebber, R L;King, M T;
Vol. 27 Suppl 1 , pp. i66-i71
338 views DOI Abstract
2005
SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004.
Haie-Meder, C;Fervers, B;Fondrinier, E;Haugh, M;Lhomme, C;Guastalla, J P;
Vol. 16 , No. 7 , pp. 1100-8
330 views Abstract
2020
COVID-19 Infection in Cancer Patients: Early Observations and Unanswered Questions.
Oh, William K;
320 views DOI
2012
International models of investigator-initiated trials: implications for Japan.
Trimble, E L;Ledermann, J;Law, K;Miyata, T;Imamura, C K;Nam, B-H;Kim, Y H;Bang, Y-J;Michaels, M;Ardron, D;Amano, S;Ando, Y;Tominaga, T;Kurokawa, K;Takebe, N;
Vol. 23 , No. 12 , pp. 3151-3155
299 views DOI Abstract
2024
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review.
Prelaj, A;Miskovic, V;Zanitti, M;Trovo, F;Genova, C;Viscardi, G;Rebuzzi, S E;Mazzeo, L;Provenzano, L;Kosta, S;Favali, M;Spagnoletti, A;Castelo-Branco, L;Dolezal, J;Pearson, A T;Lo Russo, G;Proto, C;Ganzinelli, M;Giani, C;Ambrosini, E;Turajlic, S;Au, L;Koopman, M;Delaloge, S;Kather, J N;de Braud, F;Garassino, M C;Pentheroudakis, G;Spencer, C;Pedrocchi, A L G;
Vol. 35 , No. 1 , pp. 29-65
115 views DOI Abstract
2020
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment
Fabi A;Bhargava R;Fatigoni S;Guglielmo M;Horneber M;Roila F;Weis J;Jordan K;Ripamonti CI; ;;
Vol. 31 , No. 6 , pp. -
600 views Abstract
2020
A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore.
Ngoi, Natalie;Lim, Joline;Ow, Samuel;Jen, Wei Ying;Lee, Matilda;Teo, Winnie;Ho, Jingshan;Sundar, Raghav;Tung, Moon Ley;Lee, Yee Mei;Ngo, Ednajoy;Lim, Siew Woon;Ong, Jason;Lim, Frances;Bonney, Glenn;Vellayappan, Balamurugan;Ho, Francis;Tey, Jeremy;Chan, Noreen;de Mel, Sanjay;Poon, Michelle;Lee, Shir Ying;Koh, Liang Piu;Liu, Te Chih;Tan, Lip Kun;Wong, Alvin;Wong, Andrea;Lim, Siew Eng;Yeoh, Allen;Wong, John El;Tan, David;Goh, Boon Cher;Chng, Wee Joo;Soo, Ross;Chee, Cheng Ean;Chee, Yen Lin;Lee, Soo Chin;Jeyasekharan, Anand D;, ;
357 views DOI
2020
COVID-19 Infection in Cancer Patients: Early Observations and Unanswered Questions.
Oh, William K;
320 views DOI
2019
A three-year study of epidemiological trends of gastrointestinal cancers in a Haitian cancer program.
Bernard, J;Gilbert, D;Germain, R;Alexis, L;DeGennaro, V;
Vol. 30 Suppl 4 , pp. iv20
371 views DOI
2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Jhaveri, K L;Wang, X V;Makker, V;Luoh, S-W;Mitchell, E P;Zwiebel, J A;Sharon, E;Gray, R J;Li, S;McShane, L M;Rubinstein, L V;Patton, D;Williams, P M;Hamilton, S R;Conley, B A;Arteaga, C L;Harris, L N;O'Dwyer, P J;Chen, A P;Flaherty, K T;
Vol. 30 , No. 11 , pp. 1821-1830
369 views DOI Abstract
2019
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange, M;Joly, F;Vardy, J;Ahles, T;Dubois, M;Tron, L;Winocur, G;De Ruiter, M B;Castel, H;
Vol. 30 , No. 12 , pp. 1925-1940
375 views DOI Abstract
2017
notiarrayanes: más que una práctica pedagógica, un sitio para fomentar el encuentro, el diálogo y la construcción
;Alexander Castañeda Vanegas
, No. 32 , pp. 103-108
186 views Abstract
2017
problemas y retos de la educación rural colombiana
;Jairo Arias Gaviria
, No. 33 , pp. 53-62
117 views Abstract
2016
Patient-reported outcomes (PRO) in ovarian cancer clinical trials-lost opportunities and lessons learned.
Friedlander, M;Mercieca-Bebber, R L;King, M T;
Vol. 27 Suppl 1 , pp. i66-i71
338 views DOI Abstract
41
Overall
Below Average
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

41.2/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.9/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

35.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.